Reducing the Usage of Oral Corticosteroids in the Management of Asthma: A Part of the BREATHE Initiative
Podcast 2: Immunologist
Questions marked with a
*
are required
100%
Contact Information
First Name
Last Name
Email Address
What are potential concerns when using oral corticosteroids?
Risk of diabetes
Risk of osteoporosis
Risk of worsening exacerbations
A and B
All of the above
The biologic data in patients with moderate-to-severe asthma demonstrates:
That co-morbidities, like nasal polyps, can be effectively treated along with the patient’s asthma
That some of the biologic agents can reduce and potentially eliminate the need for oral corticosteroids
That a patient’s biomarkers can predict the efficacy of specific biologics
A and B
All of the above
Morgan is a 48-year-old woman (5’ 4”, 160 lbs). Her asthma was diagnosed by her internist 2 years ago. Her last exacerbation was 2 months ago. She has been referred to you with the following past medical history.
Frequent productive cough
Exacerbations (wheezing, coughing, SOB) every 3-5 months with the last episode requiring oral corticosteroids
Her past medical history is significant for:
Chronic sinusitis without nasal polyps
Prior asthma medications were:
Fluticasone propionate/ salmeterol 500 μg/50 μg twice daily
Current asthma medications are (started 6 months ago):
High-dose budesonide/formoterol fumarate dihydrate inhaler
Tiotropium inhaler
Prednisone 15 mg PO daily (started 2 months ago)
What risks are you concerned with secondary to her oral corticosteroids?
Osteoporosis
Weight gain
Dose is low enough, so no concerns
A and B
Submit
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close